What is baseline testing?
Baseline testing, sometimes referred to as ovarian reserve testing, is a medical assessment which provides your fertility physician a comprehensive look at your fertility potential. It may be used to determine your cycle protocol and initial medication dosages. It can also predict your ovarian response during your egg donation cycle. Baseline testing is performed as part of the egg donor screening process and commonly includes an antral follicle count, as well as both follicle-stimulating hormone and anti-müllerian hormone testing.
Antral follicle count
An antral follicle count (AFC) is performed by transvaginal ultrasound. During the ultrasound, a physician or ultrasonographer will count the number of resting follicles you have on your ovaries. These follicles have the potential to grow and mature during an egg donation cycle.
Follicle-stimulating hormone (FSH) is a hormone responsible for the production of mature eggs. It is released by the anterior pituitary gland and stimulates egg maturation on your ovaries. Your FSH testing is performed by blood draw. This hormone is drawn just after the onset of your menstrual period.
Anti-Müllerian hormone (AMH) is a hormone produced by the granulosa cells of your ovarian pre-antral follicles. AMH helps predict your response to medication by giving your doctor an accurate, objective view of your ovarian reserve. Your AMH testing is performed by blood draw. This hormone can be tested at any point during your monthly cycle.
Overall, egg donor baseline testing commonly comprises AFC, FSH, and AMH. The results, when taken into consideration as a whole, can provide your fertility physician the ability to assess your reproductive potential and suitability for egg donation. If you would like more information about baseline testing, contact our office today.